These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37921016)

  • 1. Neurovisual rehabilitation in multiple sclerosis: Why a close integration of low-vision rehabilitation and neuropsychological rehabilitation may be effective for visual complaints.
    van der Feen FE; de Haan GA; van der Lijn I; Heersema DJ; Meilof JF; Heutink J
    Clin Rehabil; 2024 Mar; 38(3):393-402. PubMed ID: 37921016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complex relation between visual complaints and decline in visual, visuoperceptual and cognitive functions in people with multiple sclerosis.
    van der Feen FE; de Haan GA; van der Lijn I; Stellingwerf C; Vrijling ACL; Heersema DJ; Meilof JF; Heutink J
    Neuropsychol Rehabil; 2024 Mar; 34(2):220-243. PubMed ID: 36871257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis.
    Schinzel J; Zimmermann H; Paul F; Ruprecht K; Hahn K; Brandt AU; Dörr J
    BMC Neurol; 2014 Feb; 14():31. PubMed ID: 24555757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual acuity is associated with performance on visual and non-visual neuropsychological tests in multiple sclerosis.
    Feaster HT; Bruce JM
    Clin Neuropsychol; 2011 May; 25(4):640-51. PubMed ID: 21512957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One eye or two: a comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis.
    Pineles SL; Birch EE; Talman LS; Sackel DJ; Frohman EM; Calabresi PA; Galetta SL; Maguire MG; Balcer LJ
    Am J Ophthalmol; 2011 Jul; 152(1):133-40. PubMed ID: 21570055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual and cognitive functioning among older adults with low vision before vision rehabilitation: A pilot study.
    Aubin G; Phillips N; Jaiswal A; Johnson AP; Joubert S; Bachir V; Kehayia E; Wittich W
    Front Psychol; 2023; 14():1058951. PubMed ID: 37034930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity.
    Mowry EM; Loguidice MJ; Daniels AB; Jacobs DA; Markowitz CE; Galetta SL; Nano-Schiavi ML; Cutter GR; Maguire MG; Balcer LJ
    J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):767-72. PubMed ID: 19240050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is neuropsychological rehabilitation effective in multiple sclerosis?
    Hämäläinen P; Rosti-Otajärvi E
    Neurodegener Dis Manag; 2014; 4(2):147-54. PubMed ID: 24832032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite.
    Balcer LJ; Baier ML; Cohen JA; Kooijmans MF; Sandrock AW; Nano-Schiavi ML; Pfohl DC; Mills M; Bowen J; Ford C; Heidenreich FR; Jacobs DA; Markowitz CE; Stuart WH; Ying GS; Galetta SL; Maguire MG; Cutter GR
    Neurology; 2003 Nov; 61(10):1367-73. PubMed ID: 14638957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS.
    Martínez-Lapiscina EH; Fraga-Pumar E; Gabilondo I; Martínez-Heras E; Torres-Torres R; Ortiz-Pérez S; Llufriu S; Tercero A; Andorra M; Roca MF; Lampert E; Zubizarreta I; Saiz A; Sanchez-Dalmau B; Villoslada P
    BMC Res Notes; 2014 Dec; 7():910. PubMed ID: 25512202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The King-Devick (K-D) test of rapid eye movements: a bedside correlate of disability and quality of life in MS.
    Moster S; Wilson JA; Galetta SL; Balcer LJ
    J Neurol Sci; 2014 Aug; 343(1-2):105-9. PubMed ID: 24954088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive complaints by hematopoietic cell transplantation recipients and change in neuropsychological performance over time.
    LaLonde L; Votruba K; Kentor R; Gatza E; Choi SW; Hoodin F
    Support Care Cancer; 2021 Jan; 29(1):247-254. PubMed ID: 32346799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive rehabilitation in multiple sclerosis: a randomized controlled trial.
    Hanssen KT; Beiske AG; Landrø NI; Hofoss D; Hessen E
    Acta Neurol Scand; 2016 Jan; 133(1):30-40. PubMed ID: 25952561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rate of neuropsychological assessments in multiple sclerosis has increased-A retrospective study in a Finnish Central Hospital.
    Castrén E; Heinonen T; Mäkinen K; Hämäläinen P; Kuusisto H
    Acta Neurol Scand; 2020 Feb; 141(2):156-161. PubMed ID: 31585023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological rehabilitation for multiple sclerosis.
    Rosti-Otajärvi EM; Hämäläinen PI
    Cochrane Database Syst Rev; 2011 Nov; (11):CD009131. PubMed ID: 22071863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study.
    Wieder L; Gäde G; Pech LM; Zimmermann H; Wernecke KD; Dörr JM; Bellmann-Strobl J; Paul F; Brandt AU
    BMC Neurol; 2013 Nov; 13():167. PubMed ID: 24206900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vision in a phase 3 trial of natalizumab for multiple sclerosis: relation to disability and quality of life.
    Chahin S; Balcer LJ; Miller DM; Zhang A; Galetta SL
    J Neuroophthalmol; 2015 Mar; 35(1):6-11. PubMed ID: 25370598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Don't be late! Timely identification of cognitive impairment in people with multiple sclerosis: a study protocol.
    Waskowiak PT; de Jong BA; Uitdehaag BMJ; Saddal SRD; Aarts J; Roovers AAM; van Oirschot P; de Groot V; Schaafsma FG; van der Hiele K; Ruitenberg MFL; Schoonheim MM; Widdershoven GAM; van der Veen S; Schippers ECF; Klein M; Hulst HE;
    BMC Neurol; 2024 Jan; 24(1):26. PubMed ID: 38218777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire.
    Ma SL; Shea JA; Galetta SL; Jacobs DA; Markowitz CE; Maguire MG; Balcer LJ
    Am J Ophthalmol; 2002 May; 133(5):686-92. PubMed ID: 11992867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The possibilities of neuropsychological rehabilitation in multiple sclerosis].
    Rosti-Otajärvi E; Hämäläinen P
    Duodecim; 2010; 126(24):2845-52. PubMed ID: 21268907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.